Triethylamine → 4-[1,2,4]Triazol-1-yl-benzoic acid 3-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ylcarbamoyl)-benzylamide

HRID 2367741Notes

Reaction equation

HRID 2367741 reaction equation
[N:1]1([C:6]2[CH:14]=[CH:13][C:9]([C:10]([OH:12])=O)=[CH:8][CH:7]=2)[CH:5]=[N:4][CH:3]=[N:2]1.Cl.Cl.[NH2:17][CH2:18][C:19]1[CH:20]=[C:21]([CH:36]=[CH:37][CH:38]=1)[C:22]([NH:24][C:25]1[CH:34]=[C:33]2[C:28]([CH2:29][CH2:30][N:31]([CH3:35])[CH2:32]2)=[CH:27][CH:26]=1)=[O:23].C(N(CC)CC)C>CN(C=O)C.O.FC(F)(F)C(O)=O>[CH3:35][N:31]1[CH2:30][CH2:29][C:28]2[C:33](=[CH:34][C:25]([NH:24][C:22]([C:21]3[CH:20]=[C:19]([CH:38]=[CH:37][CH:36]=3)[CH2:18][NH:17][C:10](=[O:12])[C:9]3[CH:8]=[CH:7][C:6]([N:1]4[CH:5]=[N:4][CH:3]=[N:2]4)=[CH:14][CH:13]=3)=[O:23])=[CH:26][CH:27]=2)[CH2:32]1

Participants

7

Procedure

Dissolve 4-[1,2,4]triazol-1-yl-benzoic acid (29 mg, 0.15 mmol) and CDI (N,N′-carbonyldiimidazole) (25 mg, 0.15 mmol) in DMF (2 mL) and stir the mixture for 1 h. To this add 3-aminomethyl-N-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-benzamide dihydrochloride (50 mg, 0.14 mmol) and triethylamine (0.095 mL, 0.68 mmol) and stir the mixture overnight. Dilute the mixture with water (1 mL) and trifluoroacetic acid (0.2 mL) and purify by prep-HPLC (5%-70%, CH3CN/H2O) to give the desired product 4-[1,2,4]triazol-1-yl-benzoic acid 3-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ylcarbamoyl)-benzylamide (51 mg, 0.086 mmol). MS, electrospray 467.4 (M+H), rt 1.05 min.

Workup

  1. custompurify by prep-HPLC (5%-70%, CH3CN/H2O)

Sources & evidence

ORD record
ord-b55b6da6675d4c178bf3050d6b670a22
Source dataset
uspto-grants-2014_04
Patent number
US08697911B2

Reaction notes

Loading…